title: Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.
abstract: The extracellular domain of tumour necrosis factor-alpha (TNF-alpha) receptors have inhibitory properties against TNF-alpha. The relative ratio between ligand and ligand inhibitors may influence the outcome of meningococcaemia. To test this hypothesis, levels of TNF-alpha and of each of the soluble inhibitory fragments originating from two distinct TNF-alpha receptors (sTNF-RI and sTNF-RII) were measured in sera of children with severe meningococcaemia. On admission to the hospital the levels of sTNF-RI, -RII and TNF-alpha were markedly increased and all three correlated with the outcome of the disease. A correlation was found between TNF-alpha and sTNF-RI (P less than 0.001 by Pearson rank correlation coefficient) or sTNF-RII (P = 0.012). For TNF-alpha concentrations below 500 pg/ml, the increase of TNF-alpha was proportional to that of sTNF-RI and RII; however, when TNF-alpha levels exceeded 500 pg/ml, sTNF-RI and RII concentrations did not increase proportionally. At admission, in patients with fatal outcome, the ratios TNF-alpha/sTNF-RI and -RII were higher than in survivors. During the first 6 hr, the kinetics of TNF-alpha, sTNF-RI and -RII were different. Naturally occurring TNF-alpha inhibitors may play an important role in modulating the biological activity of TNF-alpha in severe meningococcaemia.
authors.affiliation: Department of Pediatrics, Hôpital Cantonal, Geneva, Switzerland.
authors.forename: E
authors.initials: E
authors.lastname: Girardin
authors.forename: P
authors.initials: P
authors.lastname: Roux-Lombard
authors.forename: G E
authors.initials: GE
authors.lastname: Grau
authors.forename: P
authors.initials: P
authors.lastname: Suter
authors.forename: H
authors.initials: H
authors.lastname: Gallati
authors.forename: J M
authors.initials: JM
authors.lastname: Dayer
mesh_terms: D016470:Bacteremia / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism; D008585:Meningitis, Meningococcal / Q000097:blood* / Q000276:immunology / Q000401:mortality; D011379:Prognosis; D011956:Receptors, Cell Surface / Q000378:metabolism*; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D015850:Interleukin-6; D011956:Receptors, Cell Surface; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha